This inventor holds 1 USPTO granted patent. Top assignees: Assistance Publique-Hopitaux De Paris, Centre National De La Recherche Scientifique, Institut Curie. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 331 
1 out of 5,383 
1 out of 163 
Years Active: 2016
Title: Nicolas Stransky: Innovator in Cancer Treatment
Introduction
Nicolas Stransky is a notable inventor based in Le Kremlin Bicetre, France. He has made significant contributions to the field of cancer research, particularly through his innovative approaches to treatment.
Latest Patents
Stransky holds a patent for "Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancer." This invention focuses on new methods for treating cancer by utilizing TYRO3 inhibitors. It also includes methods for identifying new molecules that could be beneficial in cancer treatment.
Career Highlights
Throughout his career, Nicolas Stransky has worked with prestigious institutions such as Institut Curie and the Centre National de la Recherche Scientifique. His work has been instrumental in advancing cancer therapies and understanding the mechanisms involved in tumor growth.
Collaborations
Stransky has collaborated with esteemed colleagues, including Isabelle Bernard-Pierrot and Francois Radvanyi. These partnerships have further enriched his research and contributed to the development of innovative cancer treatments.
Conclusion
Nicolas Stransky's work exemplifies the impact of innovative thinking in the medical field, particularly in cancer treatment. His contributions continue to pave the way for new therapeutic strategies that could benefit countless patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile